Damora Therapeutics, Inc.
DMRA· Nasdaq
Damora Therapeutics, Inc.
- Last sale
- Oct 2, 2026 · +2.22%
- Market cap
- $1.28B
- 61.74M shares
- Filings
- 352
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Net Interest Income
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $1,167,000 | reported | |
| FY 2024 | 2024-12-31 | $844,000 | reported | |
| FY 2023 | 2023-12-31 | $1,689,000 | reported | |
| FY 2022 | 2022-12-31 | $722,000 | reported | |
| FY 2021 | 2021-12-31 | $156,000 | reported |
Damora Therapeutics, Inc. · CIK 1800315 · Engraved from SEC EDGAR
